AURA
Price
$6.71
Change
-$0.41 (-5.76%)
Updated
Jul 18 closing price
Capitalization
416.05M
17 days until earnings call
VRDN
Price
$16.52
Change
-$0.53 (-3.11%)
Updated
Jul 18 closing price
Capitalization
1.35B
16 days until earnings call
Interact to see
Advertisement

AURA vs VRDN

Header iconAURA vs VRDN Comparison
Open Charts AURA vs VRDNBanner chart's image
Aura Biosciences
Price$6.71
Change-$0.41 (-5.76%)
Volume$213.14K
Capitalization416.05M
Viridian Therapeutics
Price$16.52
Change-$0.53 (-3.11%)
Volume$511.54K
Capitalization1.35B
AURA vs VRDN Comparison Chart in %
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. VRDN commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and VRDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (AURA: $6.71 vs. VRDN: $16.52)
Brand notoriety: AURA and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 97% vs. VRDN: 69%
Market capitalization -- AURA: $416.05M vs. VRDN: $1.35B
AURA [@Biotechnology] is valued at $416.05M. VRDN’s [@Biotechnology] market capitalization is $1.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 3 bearish.
  • VRDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AURA is a better buy in the short-term than VRDN.

Price Growth

AURA (@Biotechnology) experienced а -0.89% price change this week, while VRDN (@Biotechnology) price change was -3.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

AURA is expected to report earnings on Aug 07, 2025.

VRDN is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.35B) has a higher market cap than AURA($416M). VRDN YTD gains are higher at: -13.824 vs. AURA (-18.370). AURA has higher annual earnings (EBITDA): -101.63M vs. VRDN (-304.76M). VRDN has more cash in the bank: 637M vs. AURA (128M). AURA has less debt than VRDN: AURA (18.4M) vs VRDN (21.2M). VRDN has higher revenues than AURA: VRDN (302K) vs AURA (0).
AURAVRDNAURA / VRDN
Capitalization416M1.35B31%
EBITDA-101.63M-304.76M33%
Gain YTD-18.370-13.824133%
P/E RatioN/AN/A-
Revenue0302K-
Total Cash128M637M20%
Total Debt18.4M21.2M87%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAVRDN
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 21 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSRGY96.480.83
+0.87%
Nestle S.A.
RMIAF0.76N/A
N/A
Automotive Finco Corp.
SSPPF2.15N/A
N/A
SSP Group PLC
ZLDSF30.51N/A
N/A
ZALANDO SE
ANSNF0.04-0.01
-26.13%
Anson Resources

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-5.76%
IDYA - AURA
53%
Loosely correlated
-2.26%
VRDN - AURA
52%
Loosely correlated
-3.11%
MGTX - AURA
52%
Loosely correlated
N/A
BEAM - AURA
50%
Loosely correlated
+1.47%
XNCR - AURA
49%
Loosely correlated
-1.10%
More

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with AURA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-3.11%
AURA - VRDN
52%
Loosely correlated
-5.76%
DNLI - VRDN
52%
Loosely correlated
-3.65%
DSGN - VRDN
50%
Loosely correlated
-1.00%
BEAM - VRDN
49%
Loosely correlated
+1.47%
IDYA - VRDN
49%
Loosely correlated
-2.26%
More